ALK and lung cancer: Our main clinic findings of our study were as follows: (1) ALK-rearranged lung cancers were more frequent in younger patients compared with the common drive mutation group (p = 0.023), in agreement with previous studies [4], [15], while there was no significance difference compared with patients in pan-negative group (p = 0.83).